Last updated: May 3, 2026
Who Supplies Lidocaine Hydrochloride Preservative-Free?
Lidocaine hydrochloride preservative-free (PF) is supplied by a mix of branded generics, global sterile injectables/solutions manufacturers, and specialty sterile drug packagers. The market is fragmented by dosage form (injection vs. dental local anesthetic cartridges), pack size, concentration, and sterile manufacturing footprint. Core supplier roles in the supply chain fall into three buckets:
- Makers of sterile active drug substance formulations (often bulk solution or finished sterile drug products)
- Contract sterile manufacturers / fill-finish sites for preservative-free labeling
- US market licensors / distributors that list the product as supplied and vend under national drug codes (NDCs)
Because “lidocaine hydrochloride preservative free” is a label attribute, the most actionable way to identify suppliers is by NDC-linked product listings and associated manufacturers of record for each concentration and container.
What product scope does this cover?
“Lidocaine hydrochloride preservative free” is commonly sold as:
- Lidocaine HCl injection, preservative free, used for local anesthesia (procedure-based use in hospital and ambulatory settings)
- PF solutions packaged in single-dose vials/amps (and sometimes unit-of-use formats depending on label)
- Concentration-dependent SKUs (commonly 1% and 2%, but the specific set depends on NDC)
The practical procurement unit is the NDC for the exact concentration and container, not the umbrella phrase.
Which suppliers are most consistently present in preservative-free lidocaine injection?
Below are supplier types you will see repeatedly in product registrations and distribution channels for preservative-free lidocaine injection, including those that routinely support sterile injectables through fill-finish and finished drug manufacturing.
1) Large sterile injectable manufacturers and fill-finish operators
These groups typically supply finished sterile products or provide fill-finish for preservative-free solutions:
| Supplier category |
Typical role |
Product match to “PF” requirement |
| Sterile injectable manufacturers |
Finished drug production |
Makes preservative-free versions under CGMP sterile standards |
| Fill-finish CDMOs |
Aseptic filling and packaging |
Produces preservative-free vials/amps for branded generics |
| Global sterile specialists |
CMOs for sterile solutions |
Supports single-dose preservative-free presentation |
2) US drug manufacturers listing preservative-free lidocaine HCl injection
In the US market, suppliers often appear as manufacturers of record on NDCs for lidocaine HCl PF injection. The supplier can change by:
- concentration (1% vs 2%)
- packaging (vial size, ampules)
- dosage form and labeling
3) Distribution-only wholesalers
Wholesalers list product availability and pricing but do not manufacture the sterile PF product.
What procurement evidence ties a supplier to a specific lidocaine HCl PF product?
A supplier is “real” for contracting and sourcing when you can map:
- NDC
- Dosage strength
- Container type
- Manufacturer of record / labeler
- Sterile product status
- Labeling that explicitly states “preservative free”
That mapping is what lets procurement teams lock:
- supply reliability
- substitution rules
- regulatory consistency in facilities
Supplier list by dosage strength and container (NDC-linked approach)
A complete supplier list requires NDC-by-NDC identification. Without NDCs and specific concentration/container, a single global supplier list risks mixing:
- preservative-containing lidocaine products
- different lidocaine salts (only lidocaine hydrochloride qualifies here)
- non-injection local anesthetic formats
For an accurate “who supplies” answer at the level buyers need, suppliers must be enumerated per SKU.
Key decision rules for selecting a supplier for PF lidocaine
Procurement teams should evaluate supplier capability along four hard dimensions:
- Sterile manufacturing model
- Finished sterile manufacture vs. fill-finish supply chain
- Preservative-free formulation control
- Label explicitly states “preservative free” (not “low preservative” or “no benzyl alcohol” unless that matches labeling)
- Supply continuity
- Availability by NDC and package size
- Regulatory labeling alignment
- Same NDC family as used in facility protocols
Key Takeaways
- “Lidocaine hydrochloride preservative free” is best sourced by NDC (strength and container), not by generic phrasing.
- Suppliers typically fall into sterile injectable manufacturers, fill-finish sterile operators, and labelers/distributors.
- The only contract-grade way to enumerate “suppliers” is NDC-linked manufacturer-of-record listings matching the exact PF-labeled product.
FAQs
-
Is “lidocaine hydrochloride preservative free” always injection?
No. It is commonly an injectable sterile product, but supplier identification must track the exact labeled dosage form.
-
Why do supplier names change for the same lidocaine PF strength?
NDC labeling and manufacturer-of-record can vary by package size, manufacturing site, and labeler.
-
Can a distributor be the supplier?
Distributors often sell the product but do not manufacture it. The manufacturer-of-record is the actionable supplier for contracting.
-
What is the most reliable procurement identifier?
The NDC, paired with strength and container.
-
What determines whether a product is truly “preservative free”?
The product labeling and formulation controls tied to that specific NDC.
References
[1] FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. US Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/
[2] DailyMed. Drug Label Information (search “lidocaine hydrochloride preservative free”). NIH/NLM. https://dailymed.nlm.nih.gov/dailymed/
